Related Experiment Videos

Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities

S Strudwick1, K L B Borden

  • 1Structural Biology Program, Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York University, New York 10029, USA.

Leukemia
|October 3, 2002
PubMed

Insights

Promyelocytic leukemia protein (PML) nuclear bodies are crucial for normal cell function and disrupted in acute promyelocytic leukemia (APL). This review clarifies PML

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Promyelocytic leukemia protein (PML) localizes to nuclear bodies in mammalian cells.
  • PML and its nuclear bodies are disrupted in acute promyelocytic leukemia (APL).
  • All-trans retinoic acid (ATRA) treatment in APL patients restores PML nuclear bodies and induces remission.

Purpose of the Study:

  • To review and simplify the complex field of PML protein function.
  • To identify well-supported models of PML nuclear body function based on strict criteria.

Main Methods:

  • Literature review of PML protein and PML nuclear body research.
  • Analysis of studies investigating PML's role in cellular regulation.
  • Application of strict criteria to evaluate proposed models of PML function.

Main Results:

  • PML protein acts as a negative growth regulator, inducing G1 cell cycle arrest, senescence, and apoptosis.
  • The structural integrity of PML nuclear bodies is essential for normal cellular functions.
  • Numerous potential PML partner proteins suggest diverse regulatory roles.

Conclusions:

  • PML nuclear bodies are critical for normal cellular functions, with their disruption linked to APL.
  • Further research is needed to define a discrete biochemical and molecular model for PML function.
  • This review aims to consolidate understanding by focusing on well-supported functional models of PML bodies.

Related Concept Videos